Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
Jan Zaloga,1 Christina Janko,1 Johannes Nowak,2 Jasmin Matuszak,1 Sabine Knaup,1 Dietmar Eberbeck,3 Rainer Tietze,1 Harald Unterweger,1 Ralf P Friedrich,1 Stephan Duerr,1 Ralph Heimke-Brinck,4 Eva Baum,4 Iwona Cicha,1 Frank Dörje,4 Stefan Odenbach,2 Stefan Lyer,1 Geoffrey Lee,5 Christoph A...
Guardado en:
Autores principales: | Zaloga J, Janko C, Nowak J, Matuszak J, Knaup S, Eberbeck D, Tietze R, Unterweger H, Friedrich RP, Duerr S, Heimke-Brinck R, Baum E, Cicha I, Dörje F, Odenbach S, Lyer S, Lee G, Alexiou C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93d1d37bec054008bb9a0b63b7dfbf18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles
por: Matuszak J, et al.
Publicado: (2018) -
Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
por: Unterweger H, et al.
Publicado: (2017) -
Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods
por: Friedrich RP, et al.
Publicado: (2015) -
Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery
por: Unterweger H, et al.
Publicado: (2014) -
Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake
por: Poller JM, et al.
Publicado: (2017)